PubMed:17255138 / 1068-1377 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCoin-entities

Id Subject Object Predicate Lexical cue db_id
3905 19-26 ChemicalEntity denotes aspirin MESH:D001241
3906 104-107 DiseaseOrPhenotypicFeature denotes AMI MESH:D009203
3907 118-131 ChemicalEntity denotes acetaminophen MESH:D000082
3908 141-148 ChemicalEntity denotes aspirin MESH:D001241
3909 162-171 ChemicalEntity denotes rofecoxib MESH:C116926
3910 191-200 ChemicalEntity denotes celecoxib MESH:C105934
3911 220-228 ChemicalEntity denotes naproxen MESH:D009288
3912 248-258 ChemicalEntity denotes diclofenac MESH:D004008
3913 281-290 ChemicalEntity denotes ibuprofen MESH:D007052

LitCoin-sentences

Id Subject Object Predicate Lexical cue
T14 0-309 Sentence denotes Among non-users of aspirin, the adjusted hazard ratios (95% confidence interval) of hospitalization for AMI/GI vs the acetaminophen (with no aspirin) group were: rofecoxib 1.27 (1.13, 1.42), celecoxib 0.93 (0.83, 1.03), naproxen 1.59 (1.31, 1.93), diclofenac 1.17 (0.99, 1.38) and ibuprofen 1.05 (0.74, 1.51).

LitCoin-GeneOrGeneProduct-v0

Id Subject Object Predicate Lexical cue
T17 104-107 GeneOrGeneProduct denotes AMI
T18 108-110 GeneOrGeneProduct denotes GI

LitCoin_Mondo_095

Id Subject Object Predicate Lexical cue mondo_id
T9 104-107 DiseaseOrPhenotypicFeature denotes AMI 0004781

LitCoin-MeSH-Disease-2

Id Subject Object Predicate Lexical cue ID:
T6 104-107 DiseaseOrPhenotypicFeature denotes AMI DISEASE

LitCoin-MONDO_bioort2019

Id Subject Object Predicate Lexical cue #label
T5 104-107 DiseaseOrPhenotypicFeature denotes AMI DISEASE

LitCoin-Chemical-MeSH-CHEBI

Id Subject Object Predicate Lexical cue ID:
T27 19-26 ChemicalEntity denotes aspirin D001241
T28 104-107 ChemicalEntity denotes AMI http://purl.obolibrary.org/obo/CHEBI_65009
T29 118-131 ChemicalEntity denotes acetaminophen D000082
T30 141-148 ChemicalEntity denotes aspirin D001241
T31 162-171 ChemicalEntity denotes rofecoxib C116926|http://purl.obolibrary.org/obo/CHEBI_8887
T33 191-200 ChemicalEntity denotes celecoxib D000068579|http://purl.obolibrary.org/obo/CHEBI_41423
T35 220-228 ChemicalEntity denotes naproxen D009288|http://purl.obolibrary.org/obo/CHEBI_7476|http://purl.obolibrary.org/obo/CHEBI_59527
T38 248-258 ChemicalEntity denotes diclofenac D004008|http://purl.obolibrary.org/obo/CHEBI_47381
T40 281-290 ChemicalEntity denotes ibuprofen D007052|http://purl.obolibrary.org/obo/CHEBI_5855|http://purl.obolibrary.org/obo/CHEBI_132922

LitCoin-NCBITaxon-2

Id Subject Object Predicate Lexical cue
T5 104-107 OrganismTaxon denotes AMI

LitCoin-training-merged

Id Subject Object Predicate Lexical cue #label ID:
T40 281-290 ChemicalEntity denotes ibuprofen http://purl.obolibrary.org/obo/CHEBI_132922|http://purl.obolibrary.org/obo/CHEBI_5855|D007052
T38 248-258 ChemicalEntity denotes diclofenac http://purl.obolibrary.org/obo/CHEBI_47381|D004008
T35 220-228 ChemicalEntity denotes naproxen http://purl.obolibrary.org/obo/CHEBI_59527|http://purl.obolibrary.org/obo/CHEBI_7476|D009288
T33 191-200 ChemicalEntity denotes celecoxib http://purl.obolibrary.org/obo/CHEBI_41423|D000068579
T31 162-171 ChemicalEntity denotes rofecoxib http://purl.obolibrary.org/obo/CHEBI_8887|C116926
T30 141-148 ChemicalEntity denotes aspirin D001241
T29 118-131 ChemicalEntity denotes acetaminophen D000082
T28 104-107 ChemicalEntity denotes AMI http://purl.obolibrary.org/obo/CHEBI_65009
T27 19-26 ChemicalEntity denotes aspirin D001241
T47343 104-107 DiseaseOrPhenotypicFeature denotes AMI DISEASE
T71975 104-107 OrganismTaxon denotes AMI